BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37427096)

  • 1. Genomic profiles of renal cell carcinoma in a small Chinese cohort.
    Tai S; Xu DD; Yu Z; Guan Y; Yin S; Xiao J; Xue S; Liang C
    Front Oncol; 2023; 13():1095775. PubMed ID: 37427096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With
    Liu Y; Li Y; Xu H; Zhou L; Yang X; Wang C
    Int J Surg Pathol; 2023 Dec; 31(8):1485-1494. PubMed ID: 36911986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
    Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
    World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
    Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
    Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population.
    Suh J; Jeong CW; Choi S; Ku JH; Kim HH; Kim K; Kwak C
    BMC Urol; 2020 Aug; 20(1):125. PubMed ID: 32811483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
    Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
    Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma.
    Feng H; Cao S; Ouyang Q; Li H; Li X; Chen K; Zhang X; Huang Y; Zhang X; Ma X
    Transl Androl Urol; 2023 Feb; 12(2):308-319. PubMed ID: 36915884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
    Karlo CA; Di Paolo PL; Chaim J; Hakimi AA; Ostrovnaya I; Russo P; Hricak H; Motzer R; Hsieh JJ; Akin O
    Radiology; 2014 Feb; 270(2):464-71. PubMed ID: 24029645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
    Ibragimova I; Maradeo ME; Dulaimi E; Cairns P
    Epigenetics; 2013 May; 8(5):486-93. PubMed ID: 23644518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP1-Mutated Clear Cell Renal Cell Carcinoma.
    Gallan AJ; Parilla M; Segal J; Ritterhouse L; Antic T
    Am J Clin Pathol; 2021 Apr; 155(5):718-728. PubMed ID: 33210135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
    de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
    Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
    Sekine Y; Iwasaki Y; Aoi T; Endo M; Hirata M; Kamatani Y; Matsuda K; Sugano K; Yoshida T; Murakami Y; Fukui T; Akamatsu S; Ogawa O; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
    Hum Mol Genet; 2022 Jun; 31(12):1962-1969. PubMed ID: 35764097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma.
    Bihr S; Ohashi R; Moore AL; Rüschoff JH; Beisel C; Hermanns T; Mischo A; Corrò C; Beyer J; Beerenwinkel N; Moch H; Schraml P
    Neoplasia; 2019 Feb; 21(2):247-256. PubMed ID: 30660076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.
    Casuscelli J; Becerra MF; Manley BJ; Zabor EC; Reznik E; Redzematovic A; Arcila ME; Tennenbaum DM; Ghanaat M; Kashan M; Stief CG; Carlo M; Voss MH; Feldman DR; Motzer RJ; Chen Y; Reuter VE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA
    Eur Urol Focus; 2019 Jul; 5(4):642-649. PubMed ID: 28951115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBRM1 and BAP1 as novel targets for renal cell carcinoma.
    Brugarolas J
    Cancer J; 2013; 19(4):324-32. PubMed ID: 23867514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing.
    Lin PH; Huang CY; Yu KJ; Kan HC; Liu CY; Chuang CK; Lu YC; Chang YH; Shao IH; Pang ST
    Oncol Lett; 2021 Feb; 21(2):169. PubMed ID: 33456545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
    Wilson NR; Acikgoz Y; Hasanov E
    Int J Cancer; 2024 Mar; 154(6):947-961. PubMed ID: 37823185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.
    Huang J; Cai W; Cai B; Kong W; Zhai W; Zhang J; Chen Y; Chen S; Bai Y; Huang Y; Xue W
    Front Oncol; 2021; 11():697219. PubMed ID: 34568025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.
    Takeda K; Bastacky S; Dhir R; Mohebnasab M; Quiroga-Garza GM
    Ann Diagn Pathol; 2024 Feb; 68():152223. PubMed ID: 37976977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.